| [Fire Fighting] Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Extinguishing media: Use extinguishing media most appropriate for the surrounding fire. | |
| [Ingestion] If victim is conscious and alert, give 2-4 cupfuls of milk or water. Never give anything by mouth to an unconscious person. Get medical aid immediately. | |
| [Inhalation] Get medical aid immediately. Remove from exposure to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. | |
| [Skin] Get medical aid immediately. Flush skin with plenty of soap and water for at least 15 minutes while removing contaminated clothing and shoes. | |
| [Eyes] Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid immediately. | |
| [Storage] Store in a cool, dry place. | |
| [Handling] Wash thoroughly after handling. Use only in a well ventilated area. Avoid contact with eyes, skin, and clothing. Avoid ingestion and inhalation. | |
| [Inhalation] The toxicological properties of this substance have not been fully investigated. | |
| [Skin] May cause skin irritation. | |
| [Eyes] May cause eye irritation. | |
| [Ingestion] May cause irritation of the digestive tract. May be harmful if swallowed. May cause central nervous system effects and/or neurological effects. | |
| [Personal Protection] Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166. Skin: Wear appropriate gloves to prevent skin exposure. Clothing: Wear appropriate protective clothing to prevent skin exposure. | |
| [Respirators] Follow the OSHA respirator regulations found in 29CFR 1910.134 or European Standard EN 149. Always use a NIOSH or European Standard EN 149 approved respirator when necessary. | |
| [Exposure Effects] Prolonged or repeated exposure can cause psychic abnormalities such as anxiety, depression and excitability. Prolonged exposure may cause mental changes such as hallucinations, depression, psychosis, and possibly coma. Repeated or prolonged exposure may cause CNS stimulation. | |
| [Appearance] White crystalline powder. | |
| [Melting Point] 183 - 186 | |
| [Density] 1.198 g/cm3 | |
| [Heat Of Vaporization] | |
| [Usage] Medication. | |
| [Product Name] (1S,2S)-(+)-Pseudoephedrine hydrochloride | |
| [Synonyms] (1S,2S)-2-Methylamino-1-phenyl-propan-1-ol hydrochloride Benzenemethanol, a-[(1S)-1-(methylamino)ethyl]-, hydrochloride, (aS)- d-(1S,2S)-Pseudoephedrine hydrochloride d-[a-(1-Methylamino)ethyl]benzyl alcohol hydrochloride Novafed Sudafed | |
| [CAS] "CASEN_345-78-8.htm">345-78-8 | |
| [Formula] C10H16ClNO | |
| [Molecular Weight] 201.69 | |
| [EINECS] 206-462-1 | |
| [RTECS] UL5950000 | |
| [RTECS Class] Drug; Human Data | |
| [Beilstein/Gmelin] 3915112 | |
| [Beilstein Reference] 4-13-00-01878 | |
| [Small spills/leaks] Sweep up or absorb material, then place into a suitable clean, dry, closed container for disposal. | |
| [Incompatibilities] Light, strong oxidizing agents. | |
| [Stability] Stable under normal temperatures and pressures. | |
| [Decomposition] Carbon dioxide and carbon monoxide, hydrogen chloride gas, nitrogen oxides, various hydrocarbons. |
Print